SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-018029
Filing Date
2024-04-04
Accepted
2024-04-04 18:11:29
Documents
1
Period of Report
2024-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3004
  Complete submission text file 0001140361-24-018029.txt   4505
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. WALLSTRASSE 16 BERLIN 2M 10179
Business Address
Johnson Anne Nagengast (Reporting) CIK: 0001976640 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 24824272